NDAINTRAVENOUSSOLUTION
Approved
Nov 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
ULTRA-TECHNEKOW V4 (technetium tc-99m) by Curium Pharma is radiopharmaceutical activity [moa]. First approved in 1973.
Drug data last refreshed 16h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ULTRA-TECHNEKOW V4 is a technetium TC-99m radiopharmaceutical diagnostic agent administered intravenously as a solution. It functions through radioactive diagnostic activity to enable imaging and detection across multiple clinical indications. This legacy product has been a cornerstone of nuclear medicine since FDA approval in 1973.
LOE Approaching
A 50+ year old diagnostic radiopharmaceutical approaching loss of exclusivity signals a mature, stable but declining revenue base with a lean support team focused on operational efficiency and managed decline.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ULTRA-TECHNEKOW V4 offers limited growth trajectory but provides deep expertise in diagnostic radiopharmaceutical management, regulatory compliance, and operational excellence in a mature market. This role is better suited to professionals seeking stability and mastery of legacy product optimization rather than rapid career advancement or launch experience.
Supply Chain Manager
Worked on ULTRA-TECHNEKOW V4 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.